StockpollyBeta
Get App
Popularity #1,015
ABSI · NASDAQ · Biotechnology

Absci (ABSI)

Designs antibody drug candidates with generative AI and validates them in its own wet lab.

$10.80
After-hours close+0.12 (+1.09%)
At close$10.69(+8.81%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue101121110100
Cost of revenue1112121531716200330
Gross profit−10−11−11−14−2−16−15−200−2−30
131312132713131231342834
Research & development111212151818162019251923
000090000999
General & administrative000000000009
Other expenses210−30−5−4−911003
Operating income−23−25−23−27−29−30−28−31−30−36−31−34
112221112611
Interest expense000000000000
Other non-operating income0−1−2−2−2−1−1−1−2−6−1−1
Income before tax−22−23−22−25−27−29−26−30−29−30−30−33
Income tax expense000000000000
Net income from continuing operations−22−24−22−25−27−29−26−31−29−30−30−33
Net income−22−24−22−25−27−29−26−31−29−30−30−33
EPS, basic−$0.24−$0.25−$0.22−$0.22−$0.24−$0.25−$0.21−$0.24−$0.20−$0.20−$0.19−$0.21
EPS, diluted−$0.24−$0.25−$0.22−$0.22−$0.24−$0.25−$0.21−$0.24−$0.20−$0.20−$0.19−$0.21
Weighted average shares, basic929399113114115124128144151153157
Weighted average shares, diluted929399113114115124128144151153157
EBITDA−20−21−18−21−24−25−23−27−26−27−27−30
Depreciation & amortization433333333333
EBIT−23−24−22−25−27−28−26−30−29−30−30−33